Cargando…

Using the A/T/N Framework to Examine Driving in Preclinical Alzheimer’s Disease

The A/T/N classification system is the foundation of the 2018 NIA-AA Research Framework and is intended to guide the Alzheimer disease (AD) research agenda for the next 5–10 years. Driving is a widespread functional activity that may be particularly useful in investigation of functional changes in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roe, Catherine M., Babulal, Ganesh M., Stout, Sarah H., Carr, David B., Williams, Monique M., Benzinger, Tammie L. S., Fagan, Anne M., Holtzman, David M., Ances, Beau M., Morris, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964600/ https://www.ncbi.nlm.nih.gov/pubmed/29805967 http://dx.doi.org/10.3390/geriatrics3020023

Ejemplares similares

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

GPS driving: a digital biomarker for preclinical Alzheimer disease
por: Bayat, Sayeh, et al.
Publicado: (2021)

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

NATURALISTIC DRIVING BEHAVIOR AS A NEUROBEHAVIORAL MARKER OF PRECLINICAL ALZHEIMER’S DISEASE
por: Babulal, Ganesh
Publicado: (2019)

A Systematic Review Examining Associations between Cardiovascular Conditions and Driving Outcomes among Older Drivers
por: Babulal, Ganesh M., et al.
Publicado: (2020)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Driving Outcomes among Older Adults: A Systematic Review on Racial and Ethnic Differences over 20 Years
por: Babulal, Ganesh M., et al.
Publicado: (2018)

Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer’s Disease
por: Davis, Jennifer D., et al.
Publicado: (2020)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

Creating a driving profile for older adults using GPS devices and naturalistic driving methodology
por: Babulal, Ganesh M., et al.
Publicado: (2016)

The Road to Recovery: A Pilot Study of Driving Behaviors Following Antibody-Mediated Encephalitis
por: Day, Gregory S., et al.
Publicado: (2020)

Naturalistic driving measures of route selection associate with resting state networks in older adults
por: Wisch, Julie K., et al.
Publicado: (2022)

Association of Functional Impairments and Co-Morbid Conditions with Driving Performance among Cognitively Normal Older Adults
por: Carr, David B., et al.
Publicado: (2016)

Precipitating Mechanisms of Falls in Preclinical Alzheimer’s Disease
por: Keleman, Audrey A., et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
por: Meeker, Karin L., et al.
Publicado: (2022)

Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research
por: Babulal, Ganesh M., et al.
Publicado: (2016)

The Importance of Advancing Research on Aging and Driving
por: Murphy, Samantha A., et al.
Publicado: (2021)

Cognitive and brain reserve predict decline in adverse driving behaviors among cognitively normal older adults
por: Murphy, Samantha A., et al.
Publicado: (2022)

Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk
por: Ott, Brian R., et al.
Publicado: (2016)

Associations Between Plasma, Imaging, and Cerebrospinal Fluid Biomarkers with Driving Behavior and Cognitive Tests: Implications for Biomarker Usefulness
por: Roe, Catherine M., et al.
Publicado: (2023)

Translocator protein in late stage Alzheimer’s disease and Dementia with Lewy bodies brains
por: Xu, Jinbin, et al.
Publicado: (2019)

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
por: Bayat, Sayeh, et al.
Publicado: (2022)

Predicting driving decline and assessing crash risk in a globally aging population
por: Babulal, Ganesh M.
Publicado: (2022)

Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer’s Disease: The Role of Naturalistic Driving Studies
por: Roe, Catherine M.
Publicado: (2022)

Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease
por: Hassenstab, Jason, et al.
Publicado: (2021)

Data-driven models of dominantly-inherited Alzheimer’s disease progression
por: Oxtoby, Neil P, et al.
Publicado: (2018)

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
por: Millar, Peter R, et al.
Publicado: (2023)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
por: Day, Gregory S., et al.
Publicado: (2021)

African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
por: Schindler, Suzanne E., et al.
Publicado: (2021)

Impaired and facilitated functional networks in temporal lobe epilepsy()
por: Maccotta, Luigi, et al.
Publicado: (2013)

Driving, Social Distancing, Protective, and Coping Behaviors of Older Adults Before and During COVID-19
por: Roe, Catherine M., et al.
Publicado: (2022)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
por: Fagan, Anne M, et al.
Publicado: (2009)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders
por: Grethlein, David, et al.
Publicado: (2022)

A practitioner's guide to geospatial analysis in a neuroimaging context
por: Wisch, Julie K., et al.
Publicado: (2023)

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
por: Schindler, Suzanne Elizabeth, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ul9jbnj09jl7l5g842t7hm8rqk